Journal of IiME Volume 7 Issue 1 8th Invest in ME International ME Conference 2013 31st May 2013, London Start Presenter 07.45-08.50 Registration 08.55 09:05 09:20 10:05 10:45 10.50 11:10 11:40 12:25 12.30 13:20 13:50 14:35 15:05 15.10 15:30 16:10 16:40 17:10 17.30 Dr Ian Gibson Dr Daniel Peterson Dr Andreas Kogelnik Rakib Rayhan Plenary Refreshment Break Professor Greg Towers Professor Mady Hornig Plenary Lunch Dr Clare Gerada Professor Sonya MarshallGradisnik Dr Amolak Bansal Plenary Refreshment Break Professor Carmen Scheibenbogen Professor Olav Mella Dr Øystein Fluge Plenary Adjourn Immunological Basis of ME B-cell Depletion Therapy Using Rituximab in ME/CFS - I B-cell Depletion Therapy Using Rituximab in ME/CFS - II Dr Ian Gibson - Questions Conference Agenda Presentation Welcome to the Conference Key Note Speech: The Mainstreaming of ME Research Key Note Speech: Making ME Mainstream: Strategies for ME Research and Collaboration The Role of the Brain and ME Questions Retroviruses and ME Pathogen Discovery in ME Questions Govt NHS Reforms: Implications for long term chronic conditions such as ME – for GPs and Patients Current Knowledge of Immunological Biomarkers Clinical Immunology and Research on B-cell Abnormalities in ME Patients Questions (May 2013) Support Biomedical Research into ME. Order our free newsletter. Distributed monthly via html, plain text or PDF http://bit.ly/14Q8VoP Invest in ME (Charity Nr. 1114035) www.investinme.org Invest in ME wristbands http://bit.ly/13gKHBp Page 34 of 36
35 Publizr Home